GlassScriptPhysician profile
Mohammed S Rais
NPI 1093712028
$14,667.11
in general payments reported to CMS, 2019-2025
43 companies · $1,702 in 2025
The $1,702 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $697 · 2021: $1,228 · 2022: $1,063 · 2023: $1,216 · 2024: $7,866 · 2025: $1,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,458 · Food and Beverage: $5,315 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,458.33 |
| Food and Beverage | $5,314.50 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $7,131.51 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Alphavac |
| Novartis Pharmaceuticals Corporation | $1,079.79 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $890.79 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $699.44 | 2021-2025 | Verquvo |
| Pfizer INC. | $586.01 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $427.70 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $370.74 | 2019-2022 | |
| Amgen INC. | $365.59 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $257.38 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $256.77 | 2023-2025 | Onpattro |
| Boston Scientific Corporation | $244.98 | 2019-2025 | Eluvia |
| Abiomed | $210.60 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $184.59 | 2022-2025 | Uptravi, Opsumit |
| Novo Nordisk INC | $181.41 | 2023-2025 | Ozempic, Wegovy |
| Medtronic, INC. | $155.57 | 2021-2025 | Venaseal |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $135.87 | 2021-2025 | Evkeeza |
| Davol INC. | $134.73 | 2024 | Arista Ah Flexitip |
| Becton, Dickinson and Company | $131.65 | 2024 | Phasix Mesh |
| E.R. Squibb & Sons, L.L.C. | $118.07 | 2023-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $113.17 | 2022-2024 | Assure Wcd |
| Ethicon US, LLC | $92.42 | 2024 | Stratafix, Surgicel Nu-Knit, Dermabond Prineo |
| Bard Peripheral Vascular, INC. | $92.39 | 2020-2023 | Venclose Maven Catheter |
| Stryker Corporation | $88.17 | 2024-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Flowtriever |
| Scpharmaceuticals INC. | $83.17 | 2024-2025 | |
| Abbott Laboratories | $68.23 | 2020-2022 | |
| Amarin Pharma, INC. | $57.54 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $57.52 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $53.50 | 2021-2023 | Nexletol |
| Cvrx, INC. | $50.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $42.19 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $41.22 | 2019-2023 | Livalo |
| Surmodics, INC. | $39.66 | 2024-2025 | Sublime Microcatheter, 018, 200cm, Straight, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 035, 200cm, Angle |
| Venclose INC. | $37.16 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $34.10 | 2024 | Arcalyst |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $25.26 | 2024 | |
| Itamar Medical INC | $22.35 | 2023 | Watchpatone |
| Cardiovascular Systems INC. | $17.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.23 | 2022 | |
| Cardiva Medical, INC. | $15.70 | 2021 | |
| Gilead Sciences, INC. | $15.62 | 2019 | |
| Medtronic Vascular, INC. | $15.47 | 2019 | |
| Vifor Pharma, INC. | $13.50 | 2021 | |
| Tactile Systems Technology INC | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$30,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Rais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.